We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

75 hedge funds and large institutions have $16.3M invested in Cognition Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.38% less ownership

Funds ownership: 24.35% → 23.97% (-0.38%)

7% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 14

4% less funds holding

Funds holding: 78 → 75 (-3)

44% less capital invested

Capital invested by funds: $29M → $16.3M (-$12.8M)

Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
18
Reduced
14
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CM
CM Management
Florida
+$233K
2
XT
XTX Topco
Cayman Islands
+$185K
3
HF
HRT Financial
New York
+$178K
4
Renaissance Technologies
Renaissance Technologies
New York
+$172K
5
SPC
Sigma Planning Corp
Michigan
+$142K

Top Sellers

1
Jane Street
Jane Street
New York
-$284K
2
OAC
OMERS Administration Corp
Ontario, Canada
-$215K
3
GCM
Graham Capital Management
Connecticut
-$205K
4
Citadel Advisors
Citadel Advisors
Florida
-$157K
5
VC
Voss Capital
Texas
-$92.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
BIOS Capital Management
Texas
$4.56M – – –
VCM
2
Vanguard Capital Management
Pennsylvania
$2.28M +$3.49M +3,001,787 New
DC
3
Davenport & Co
Virginia
$2.2M +$24.4K +20,972 +0.7%
Renaissance Technologies
4
Renaissance Technologies
New York
$848K +$172K +147,623 +15%
C
5
Chescapmanager
Maryland
$757K – – –
BlackRock
6
BlackRock
New York
$735K -$53.5K -45,976 -5%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$699K +$53.8K +46,254 +5%
HCM
8
Hilton Capital Management
New York
$417K – – –
VFT
9
Vanguard Fiduciary Trust
Pennsylvania
$352K +$540K +463,684 New
DIG
10
Dauntless Investment Group
New Hampshire
$327K -$40.7K -35,000 -8%
CM
11
CM Management
Florida
$304K +$233K +200,000 +100%
Jane Street
12
Jane Street
New York
$281K -$284K -244,121 -40%
SPC
13
Sigma Planning Corp
Michigan
$257K +$142K +121,600 +56%
State Street
14
State Street
Massachusetts
$239K – – –
AFG
15
American Financial Group
Ohio
$156K – – –
VC
16
Voss Capital
Texas
$152K -$92.4K -79,340 -28%
XT
17
XTX Topco
Cayman Islands
$149K +$185K +158,576 +426%
TAM
18
Tocqueville Asset Management
New York
$148K +$2.91K +2,500 +1%
Northern Trust
19
Northern Trust
Illinois
$128K -$29.8K -25,628 -13%
HF
20
HRT Financial
New York
$116K +$178K +152,999 New
TCBWMS
21
Texas Capital Bank Wealth Management Services
Texas
$93.6K – – –
Charles Schwab
22
Charles Schwab
California
$64.5K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$61.3K +$780 +670 +0.8%
UBS Group
24
UBS Group
Switzerland
$58.3K +$2.96K +2,541 +3%
Corient Private Wealth
25
Corient Private Wealth
Florida
$54.8K -$83.9K -72,112 -50%
1
2 3 4

CGTX Hedge Fund Activity: Q1 2026 in Review

75 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q1 2026, worth a combined $16.3M — down 44% from $29M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CGTX and 13 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 18 added.

The largest buyer was CM Management, adding an estimated $233K. The largest seller was Jane Street, cutting an estimated $284K.

  • 75 institutional investors held Cognition Therapeutics (CGTX) as of Q1 2026, down from 78 in Q4 2025.
  • Funds reported $16.3M of Cognition Therapeutics stock for Q1 2026, down 44% quarter-over-quarter.
  • 13 funds opened new Cognition Therapeutics positions in Q1 2026 and 14 closed out, a net change of -1 holder.
  • The largest Cognition Therapeutics buyer in Q1 2026 was CM Management, an estimated $233K added.
  • The largest Cognition Therapeutics seller in Q1 2026 was Jane Street, an estimated $284K sold.

Based on aggregated 13F filings for Q1 2026.